Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft vs Host Disease | 20 | 2023 | 163 | 5.500 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 12 | 2023 | 245 | 2.560 |
Why?
|
| T-Lymphocytes | 8 | 2022 | 597 | 1.780 |
Why?
|
| MicroRNAs | 3 | 2022 | 447 | 1.370 |
Why?
|
| Bone Marrow Transplantation | 5 | 2023 | 149 | 1.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2022 | 226 | 0.990 |
Why?
|
| Th17 Cells | 4 | 2018 | 116 | 0.840 |
Why?
|
| Clonal Selection, Antigen-Mediated | 1 | 2021 | 2 | 0.810 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2021 | 5 | 0.810 |
Why?
|
| Lymphoid Tissue | 1 | 2021 | 30 | 0.800 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2022 | 266 | 0.800 |
Why?
|
| Mice, Knockout | 10 | 2022 | 1692 | 0.770 |
Why?
|
| Intestines | 2 | 2023 | 114 | 0.770 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 50 | 0.750 |
Why?
|
| Th1 Cells | 3 | 2018 | 101 | 0.740 |
Why?
|
| Transcriptome | 1 | 2021 | 164 | 0.710 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 498 | 0.670 |
Why?
|
| Mice | 20 | 2023 | 8474 | 0.640 |
Why?
|
| Leukemia | 4 | 2022 | 117 | 0.640 |
Why?
|
| Transplantation, Homologous | 8 | 2023 | 242 | 0.630 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2018 | 15 | 0.620 |
Why?
|
| Plasma Cells | 1 | 2018 | 19 | 0.620 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 135 | 0.610 |
Why?
|
| Scleroderma, Diffuse | 1 | 2018 | 25 | 0.610 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 132 | 0.600 |
Why?
|
| Membrane Proteins | 2 | 2022 | 617 | 0.590 |
Why?
|
| Interleukin-17 | 2 | 2016 | 62 | 0.570 |
Why?
|
| Animals | 22 | 2023 | 20881 | 0.510 |
Why?
|
| Leukemia, Experimental | 1 | 2015 | 14 | 0.510 |
Why?
|
| Graft vs Leukemia Effect | 7 | 2022 | 33 | 0.490 |
Why?
|
| Lymphocyte Activation | 7 | 2021 | 397 | 0.460 |
Why?
|
| Mice, Inbred C57BL | 7 | 2022 | 2791 | 0.430 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 532 | 0.410 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2550 | 0.350 |
Why?
|
| X-Box Binding Protein 1 | 2 | 2021 | 16 | 0.350 |
Why?
|
| Macrophages | 2 | 2021 | 647 | 0.300 |
Why?
|
| Autoantibodies | 2 | 2019 | 434 | 0.260 |
Why?
|
| Allografts | 4 | 2021 | 63 | 0.260 |
Why?
|
| Interferon-gamma | 3 | 2016 | 241 | 0.260 |
Why?
|
| T-Box Domain Proteins | 2 | 2016 | 29 | 0.260 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 329 | 0.230 |
Why?
|
| HIV Infections | 2 | 2022 | 791 | 0.210 |
Why?
|
| Interleukin-12 | 2 | 2021 | 75 | 0.210 |
Why?
|
| Immune Reconstitution | 1 | 2022 | 4 | 0.210 |
Why?
|
| Transplantation, Isogeneic | 1 | 2021 | 19 | 0.200 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 37 | 0.200 |
Why?
|
| Whole-Body Irradiation | 1 | 2021 | 52 | 0.200 |
Why?
|
| Germinal Center | 2 | 2019 | 13 | 0.200 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Pancreas | 1 | 2023 | 225 | 0.200 |
Why?
|
| Endoribonucleases | 1 | 2021 | 22 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 68 | 0.190 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 22 | 0.190 |
Why?
|
| Receptors, Interleukin | 1 | 2021 | 22 | 0.190 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 48 | 0.190 |
Why?
|
| Hypoxia | 1 | 2022 | 169 | 0.190 |
Why?
|
| Proteolysis | 1 | 2021 | 97 | 0.190 |
Why?
|
| Bacteroides fragilis | 1 | 2021 | 20 | 0.190 |
Why?
|
| Interleukins | 1 | 2021 | 79 | 0.190 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 157 | 0.190 |
Why?
|
| Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
| Marijuana Smoking | 1 | 2021 | 108 | 0.180 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
| Amyloid beta-Peptides | 1 | 2021 | 191 | 0.180 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1033 | 0.170 |
Why?
|
| Mice, Inbred DBA | 2 | 2021 | 120 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 332 | 0.170 |
Why?
|
| Receptors, Cytokine | 1 | 2019 | 19 | 0.170 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2019 | 41 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 122 | 0.160 |
Why?
|
| Staphylococcus | 1 | 2019 | 29 | 0.160 |
Why?
|
| Bacterial Translocation | 1 | 2019 | 27 | 0.160 |
Why?
|
| Phenotype | 1 | 2021 | 947 | 0.160 |
Why?
|
| Complement Activation | 1 | 2020 | 145 | 0.160 |
Why?
|
| Complement System Proteins | 1 | 2020 | 135 | 0.160 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 56 | 0.160 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 132 | 0.160 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2018 | 4 | 0.160 |
Why?
|
| Antibody Formation | 1 | 2018 | 93 | 0.150 |
Why?
|
| Models, Animal | 1 | 2019 | 252 | 0.150 |
Why?
|
| Humans | 14 | 2022 | 68618 | 0.130 |
Why?
|
| Oligonucleotides | 1 | 2015 | 34 | 0.130 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 217 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 46 | 0.120 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 40 | 0.120 |
Why?
|
| Pyrazoles | 1 | 2015 | 190 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2015 | 178 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2015 | 116 | 0.120 |
Why?
|
| Time Factors | 1 | 2021 | 4655 | 0.110 |
Why?
|
| Brain | 1 | 2021 | 2176 | 0.090 |
Why?
|
| DNA, Ribosomal | 2 | 2021 | 59 | 0.090 |
Why?
|
| DNA, Bacterial | 2 | 2021 | 150 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 852 | 0.090 |
Why?
|
| Acute Disease | 2 | 2023 | 658 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2020 | 201 | 0.070 |
Why?
|
| Prognosis | 2 | 2021 | 2093 | 0.060 |
Why?
|
| Female | 3 | 2021 | 38074 | 0.060 |
Why?
|
| Male | 3 | 2021 | 37321 | 0.060 |
Why?
|
| Gene Expression | 2 | 2016 | 770 | 0.050 |
Why?
|
| Friend murine leukemia virus | 1 | 2022 | 10 | 0.050 |
Why?
|
| Mitochondrial Dynamics | 1 | 2022 | 17 | 0.050 |
Why?
|
| Lipid A | 1 | 2022 | 9 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 46 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2022 | 98 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Mesoderm | 1 | 2023 | 231 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2022 | 73 | 0.050 |
Why?
|
| Karyopherins | 1 | 2021 | 11 | 0.050 |
Why?
|
| Oxidoreductases | 1 | 2022 | 117 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 55 | 0.050 |
Why?
|
| Interleukin-23 | 1 | 2021 | 13 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2023 | 235 | 0.050 |
Why?
|
| Virulence | 1 | 2021 | 51 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 291 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 138 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2021 | 17 | 0.050 |
Why?
|
| Isoantigens | 1 | 2021 | 26 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 90 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2021 | 99 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 247 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2021 | 238 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1034 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 369 | 0.040 |
Why?
|
| Complement Pathway, Classical | 1 | 2020 | 22 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 455 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 110 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2021 | 2689 | 0.040 |
Why?
|
| Recurrence | 1 | 2022 | 948 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 546 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 126 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 68 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 35 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 179 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2022 | 753 | 0.040 |
Why?
|
| Ceramides | 1 | 2022 | 578 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2019 | 79 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2019 | 156 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2023 | 902 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1553 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 508 | 0.040 |
Why?
|
| Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2021 | 1330 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2019 | 682 | 0.030 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 19 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2016 | 65 | 0.030 |
Why?
|
| Adenine | 1 | 2015 | 46 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2016 | 94 | 0.030 |
Why?
|
| Lymphocyte Depletion | 1 | 2015 | 34 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 301 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2015 | 48 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 56 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2015 | 38 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2014 | 8 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 7 | 0.030 |
Why?
|
| Piperidines | 1 | 2015 | 123 | 0.030 |
Why?
|
| Granzymes | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptors, CXCR3 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2015 | 195 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 77 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2016 | 195 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2014 | 87 | 0.030 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 866 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1664 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1118 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1293 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 21147 | 0.010 |
Why?
|